2020-2027 Analysis and Review Double Chamber Prefilled Syringes Market

Double Chamber Prefilled Syringes Market

Double Chamber Prefilled Syringes Market By Material (Glass and Plastic), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027

21-05-2020 REP-HC-5092 40 Tables 120 pages Format

The double chamber prefilled syringes market was valued at USD 1,628.5 Mn by 2019. Rising prevalence of chronic diseases and a significant increase in rare diseases worldwide together drive the double chamber prefilled syringes market. Increasing demand for biologics and lyophilized chemical moieties as the most effective treatment option among physicians will further propel the double chamber prefilled syringes market growth.

Double Chamber Prefilled Syringes Market

A double chamber prefilled syringe offers a unique drug formulation technique wherein the front chamber can be filled with lyophilized drug and the other chamber with the diluent. In some cases, both the chamber can be filled with a chemical moiety which needs to be co-delivered as a drug molecule to the ailing patient.

The major segments related to the double chamber prefilled syringes market are: 

By Material (2017–2027; US$ Mn)

Glass

Plastic

By Distribution Channel (2017–2027; US$ Mn)

Hospital Pharmacy

Retail Pharmacy

Others

Geography Segment (2017–2027; US$ Mn)

North America

U.S.
Canada

Europe

United Kingdom
Germany
Russia
France
Italy
Spain
Ukraine
Rest of Europe

Asia Pacific

China
Japan
Rest of Asia Pacific

Latin America (LATAM)

Brazil
Mexico
Rest of Latin America

Middle East and Africa (MEA)

GCC
Rest of MEA 

Justification for study?

  • The intention of the study is to give a comprehensive outlook of the global double chamber prefilled syringes market
  • The overall segmentation of the double chamber prefilled syringes market, by material, distribution channel and geography is minutely studied. Glass and hospital pharmacy are dominating the material and distribution channel segments respectively
  • Rising prevalence of chronic and rare diseases worldwide
  • Significant increase in the manufacturing of biologics and lyophilized drugs further increases the demand for double chamber prefilled syringes to deliver the drug to human beings

Report gist?

  • The study of the global double chamber prefilled syringes market includes qualitative analysis of factors such as drivers, restraints, and opportunities
  • The report covers a qualitative and quantitative analysis of the overall market segmented on the basis of material and distribution channel and categorization of the same at the geography level
  • This research report presents the analysis of each segment from 2017 to 2027 in which 2019 is considered as the base year. The compounded annual growth rate is calculated for the respective segments from 2020 to 2027

The study includes the profiles of major market players with a significant global and regional presence along with top company positioning 

Significant customers?

  • This study is suitable for industry participants and stakeholders in the pharmaceutical manufacturers actively engaged in the production and marketing of double chamber prefilled syringe due to the  rising prevalence of chronic and rare diseases worldwide
  • The report will benefit researchers engaged in the development of double chamber prefilled syringe for the safe administration of medicines to ailing patients
  • Managers with financial institutions looking to publish recent and forecasted statistics pertaining to double chamber prefilled syringes market
  • Financial institutions, venture capitalist, analysts, investors, government organizations, policymakers, regulatory authorities, researchers, looking for insights into the market to determine future strategies 

Segment Analysis

In the current scenario, glass is dominating the material segment for a double chamber prefilled syringes market. The inherent properties associated with glass such as transparency, non-reactivity with chemical moieties, antileaching properties, etc. increases its demand among injectable manufactures as the most preferred material. Additionally, glass prevents the reaction of oxygen vapor and water with the drug compounds present in the prefilled syringe, however, the fragile nature serves as its major limitation. Plastics are expected to register rapid market growth in the near future on account of the technological advancement in the development of cyclic olefin copolymers. Polymers exhibit minimal drug absorption, a high degree of opacity for light-sensitive biomolecules, additionally improved resilience to pH range and reduced surface reactivity further increases its demand as a material for the manufacturing of double chamber prefilled syringes worldwide.

Hospital pharmacy is currently leading the distribution channel segment for a double chamber prefilled syringes market. It is of prime importance that injectable need to be properly dispensed by the hospital pharmacist in order to prevent any fatal outcomes related to noncompliance with the prescribed dose. Retail pharmacy is gaining positive momentum in its market growth especially in the developing regions owing to the increasing demand for double chamber prefilled syringe for the treatment of chronic diseases and its ability to provide medical assistance to patients residing in remote locations.

North America is presently spearheading the geography segment for a double chamber prefilled syringes market. The rising prevalence of chronic diseases primarily drives the double chamber prefilled syringes market growth in the region. As per the latest research citings presented by the National Health Council (NHC), approximately 133 million Americans suffer from a chronic disease that requires immediate medical intervention. Furthermore, the presence of key players such as Pfizer, Inc., AbbVie, Inc., Otsuka America Pharmaceutical, Inc., etc. further propels the market growth in the region. Europe is 2nd largest regional segment primarily due to the effective collaboration between the academic research institutes and injectable manufacturers for the development of double chamber prefilled syringes. The Asia Pacific is anticipated to be the fastest-growing regional segment during the forecast period primarily due to a significant increase in the number of patients suffering from chronic diseases. Furthermore, it serves as a potential opportunity for western players to establish subsidiaries and retail outlets in the Asia Pacific region.

Select License Type

$4,600
$6,600
$13,200

Safe and Secure SSL Encrypted

Have a Question?

We will help you find what you are looking for.

Call 1-518-730-1560

Contact sales

How can we help you?

Get in touch with us or find an office closest to you.